April 2020

Larry Einhorn was recently featured on Season III, Episode 6 of “Your Stories: Conquering Cancer” podcast, Behind the Breakthroughs: The Path to a Cure for Testicular Cancer. In the podcast, Larry talks to his friend and colleague, Patrick Loehrer, MD, about how he outsmarted what was once the deadliest form of male cancer.

February 2020

Lindsay Frazier recently received an award recognizing her as an “AYA Pioneer.” The award was presented to Lindsay at the 10th Annual Texas Adolescent & Young Adult Oncology Conference.  Lindsay was recognized along with 11 others as being an AYA Pioneer – someone who has fought hard over the last 10 years to advance the field of Adolescent and Young Adult Oncology.

January 2020

Brice Fresneau has received a grant from the French Society of Pediatric Oncology to support his analysis of tumor marker decline.

October 2019

Lindsay Frazier, Jim Amatruda, Matt Murray, and Jin Piao were recently awarded an NIH grant toward validation of miRNAs as a diagnostic test.

August 2019

Jim Amatruda, Matt Murray, and Lindsay Frazier were recently awarded a Rally Foundation grant toward the development of serum miRNAs as prognostic tool.

July 2019

Jim Amatruda has recently moved from UT Southwestern to Children’s Hospital of Los Angeles where he will be serving as the Endowed Chair of Sarcoma Research.

July 2019

Congratulations to Girish Chinnaswamy, Chair of MaGIC’s Nominating and Membership Committee, who has been promoted to Head of the Division of Pediatric Oncology at Tata Memorial Hospital, Mumbai, India.

June 2019

MaGIC member Adriana Fonseca, Hospital for Sick Children, was awarded the 2019 Conquer Cancer Foundation of ASCO Brigid Leventhal Special Merit Award. Special Merit Awards are presented each year to trainees and junior faculty who have the top-ranking abstracts for the ASCO Annual Meeting. Awards were presented at the ASCO annual meeting.

May 2019

Lindsay Frazier, MaGIC Consortium Chair, was awarded an NCI UH2 grant entitled “Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors.”

April 2019

Jim Amatruda, University of Texas Southwestern Medical Center, has received a grant supporting research for prognosis and monitoring in term cell tumor patients from the Rally Foundation for Pediatric Cancer Research. Dr. Amatruda is Co-chair of MaGIC’s Biology Committee.